Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer and reported on a series of preclinical studies and the first clinical evidence indicating the ...

Results from phase 2b study, using ALTO-100 for the treatment of patients with Major Depressive Disorder, expected in the 2nd half of 2024. Results from phase 2b study, using ALTO-300 for the ...

To overcome such inherent challenges, scientists are turning to more robust molecular solutions that improve cancer cell targeting and therapeutic outcomes, among the most promising of which are ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and ...

"The studies […] exemplify progress in the rational design of [germline-targeting] HIV-1 vaccines, and what is being learned will guide [germline-targeting] programs for inducing [broadly neutralizing ...